Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.480
-0.030 (-1.99%)
Jan 17, 2025, 4:00 PM EST - Market closed
Cellectis Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Cellectis stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 372.97% from the current stock price of 1.48.
Analyst Consensus: Buy
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for Cellectis stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +237.84% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +575.68% | Jun 12, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +305.41% | May 31, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +305.41% | Nov 1, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 | Buy | Reiterates | $11 | +643.24% | Aug 8, 2023 |
Financial Forecast
Revenue This Year
44.84M
from 9.19M
Increased by 387.77%
Revenue Next Year
49.84M
from 44.84M
Increased by 11.14%
EPS This Year
-0.86
from -1.77
EPS Next Year
-1.19
from -0.86
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 58.1M | 99.9M | 26.3M | |||
| Avg | 44.8M | 49.8M | 25.8M | |||
| Low | 36.5M | 19.6M | 24.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 532.1% | 122.8% | -47.3% | |||
| Avg | 387.8% | 11.1% | -48.3% | |||
| Low | 296.6% | -56.3% | -50.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.77 | -0.84 | -0.01 |
| Avg | -0.86 | -1.19 | -0.01 |
| Low | -0.93 | -1.37 | -0.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.